A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round. . . . → Read More: AI Gene Therapy Platform Gains $100M in Early Funds
|
|||||
|
       
  |
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds 
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering. . . . → Read More: Biomanufacturing Materials Company Issues $500M IPO  One comment - (Comments are closed)  Finance  agriculture, biotechnology, chemistry, economics, engineering, equity, genomics, investment, IPO, life sciences, manufacturing, materials science, mathematics, physical sciences 
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round. . . . → Read More: Microbiome Health Company Raises $40M in Early Funds Comments are closed Finance, New products agriculture, biomedical, biotechnology, entrepreneurs, equity, investment, life sciences, pharmaceuticals 
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies Comments are closed New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, nanotechnology, pharmaceuticals, venture capital 
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, engineering, equity, genomics, investment, life sciences, mathematics, merger, physical sciences 
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round. . . . → Read More: Synthetic DNA Company Raises $24M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, venture capital 
Venture investing, a key source of capital for research-based companies, hit a record high level worldwide in the first quarter of 2021. . . . → Read More: Infographic – Global Venture Funds Hit Record High One comment - (Comments are closed) Finance entrepreneurs, equity, investment, statistics, venture capital 
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, Covid-19, equity, investment, licensing, life sciences, mathematics, nanotechnology, NIH, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread. . . . → Read More: Microsoft, Biotech Partner on Metastatic Cancer Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||